Breaking News Instant updates and real-time market news.

CTL

CenturyLink

$21.83

0.79 (3.75%)

11:40
10/19/18
10/19
11:40
10/19/18
11:40

CenturyLink Inc sees increased put activity

CenturyLink Inc sees increased put activity. The stock up 83c to $21.87 and 7.2K Nov 23 puts trade across the exchanges for $1.58. It's a customer buyer, according to data from ISE. Open interest is 1K and the market is now $1.54 to 1.60. Defensive positions in the November term are being opened as 39K October puts on CenturyLink are set to expire today (33K out of the money) and ahead of earnings on 11/8.

  • 08

    Nov

CTL CenturyLink
$21.83

0.79 (3.75%)

10/01/18
10/01/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. OPCO CUTS CHIPOTLE TO UNDERPERFORM: Oppenheimer analyst Brian Bittner downgraded Chipotle Mexican Grill (CMG) to Underperform from Perform with a $400 price target. Since its new CEO announcement in February, Chipotle is up 82% and has been upgraded 10 different times by the Street, Bittner noted. The company's "high-flying" valuation has "priced in" persistent mid-single same-store-sales and a path to at least $20 of earnings per share versus $8-$9 this year, the analyst added. His work suggests this earnings path is too optimistic, even when assuming "healthy sales." INTEL CUT TO UNDERWEIGHT BY BARCLAYS: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Underweight from Equal Weight and lowered his price target for the shares to $38 from $53. End-market tailwinds that propelled the run in shares, namely PC shortages and the slowing of server growth, are likely to reverse, Curtis believes. Further, the analyst expects Intel will see increased competition from AMD (AMD) and declining free cash flow returns. In addition, the names that have been floated in the CEO search "have yet to yield any disruptive potential candidates to take on all of these challenges," Curtis said. By squandering its manufacturing lead, the company now faces a "costly battle to retain share amidst a near-term slowing of its end markets," concluded the analyst. MKM CUTS INFINERA TO SELL: MKM Partners analyst Michael Genovese downgraded Infinera (INFN) to Sell from Neutral and lowered his price target to $5.50 from $10. The analyst said his checks suggest the company's loss of its biggest customer CenturyLink (CTL) to Ciena (CIEN) amid concerns with its ability to produce "new leading edge digital signal processors every 18-30 months". Genovese expects Infinera's upcoming guidance for Q4 and FY19 to be disappointing on revenues and margins, while his price target that assumes a valuation multiple of 0.8-times enterprise value to expected FY19 sales "reflects increasing concerns about the long-term competitiveness of the company." TEVA UPGRADED AT LEERINK, GOLDMAN: Leerink analyst Ami Fadia upgraded Teva (TEVA) to Market Perform from Underperform due to improving business fundamentals as well as the improving multiples for the overall generics sector. The analyst, who believes the company's fundamentals have improved meaningfully and put Teva in a position to pay down $3.5B in debt by YE18, raised his price target on the shares to $24 from $16. Meanwhile, Goldman Sachs analyst Jami Rubin added Teva to Goldman's Conviction List with a Buy rating, calling the recent selloff in the shares a "head scratcher." Recent concerns raised in the marketplace regarding second half of 2018 headwinds and Eli Lilly's (LLY) galcenuzemab approval were already expected and well understood, Rubin tells investors in a research note. DEUTSCHE CUTS LAM RESEARCH, APPLIED MATERIALS TO HOLD: Deutsche Bank analyst Sidney Ho downgraded Lam Research (LRCX) to Hold and lowered his price target for the shares to $170 from $230, and downgraded Applied Materials (AMAT) to Hold and lowered his price target for the shares to $43 from $58. Semicap Equipment stocks are not expensive but lack positive catalysts, Ho said. The analyst believes investor fears over that the industry has reached a cyclical peak will remain as long as the memory market stays weak. Further, he sees risk is for additional capex push-outs, especially in the first half of 2019.
10/02/18
MSCO
10/02/18
NO CHANGE
Target $9.5
MSCO
Overweight
Morgan Stanley sees opportunity in Infinera amid CenturyLink uncertainty
After a fellow analyst said that Infinera (INFN) had lost an RFP with CenturyLink (CTL) and the company rebutted that CenturyLink confirmed that a final decision has not been made, Morgan Stanley analyst Meta Marshall said she has no knowledge of the outcome beyond Infinera's assertion that the matter has not been decided. While the potential customer loss would not be a positive, Marshall noted that her base case did not assume share gains at CenturyLink, but merely that revenue could improve by CenturyLink resuming spending at the completion of its RFP process. The analyst, who sees positive potential catalysts including Coriant synergy targets being more specifically outlined at the upcoming analyst day, Infinera meeting revenue expectations in Q3 and CenturyLink potentially resolving their RFP by year end, sees an opportunity in Infinera shares at current levels and keeps an Overweight rating and $9.50 price target on the stock.
10/02/18
JEFF
10/02/18
NO CHANGE
Target $23
JEFF
Buy
CenturyLink playbook unlikely to change under new CFO, says Jefferies
Jefferies analyst Scott Goldman says a meeting with interim CFO Neel Dev reinforced his view that CenturyLink's playbook is unlikely to change. While significant cost-cutting opportunities still remain, Dev plans to emphasize revenue improving initiatives, Goldman tells investors in a research note. The analyst, who admits the initiatives will likely take time to develop and that investors remain somewhat skeptical, continues to see upside to CenturyLink shares given its EBITDA growth prospects and dividend sustainability. He keeps a Buy rating on the shares with a $23 price target.
10/03/18
RSBL
10/03/18
NO CHANGE
RSBL
Neutral
Rosenblatt raises Ciena target, lowers Infinera's on expected CenturyLink shift
Rosenblatt analyst Ryan Koontz said he now expects Ciena (CIEN) to secure the lead optical supplier contract at CenturyLink (CTL) that he and many others had previously viewed as incumbent Infinera's (INFN) to lose. Koontz, who estimates the value of the contract for Ciena at $150M-$200M per year, modestly increased his 2019 revenue and earnings estimates and raised his price target to $33 from $31, though keeps a Neutral rating on the stock given the shares' recent strength. He cut his 2019 stand-alone Infinera revenue and earnings estimates and lowered his price target on the shares to $9 from $11.50, but maintains a Buy rating given the "precipitous" recent decline in the stock.

TODAY'S FREE FLY STORIES

CTRP

Ctrip

$32.55

-1.24 (-3.67%)

14:35
02/21/19
02/21
14:35
02/21/19
14:35
Options
Ctrip.com put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 04

    Mar

  • 20

    Mar

NAII

Natural Alternatives International

$11.15

(0.00%)

14:34
02/21/19
02/21
14:34
02/21/19
14:34
Hot Stocks
Natural Alternatives International hires David Brook for sports nutrition unit »

Natural Alternatives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

14:24
02/21/19
02/21
14:24
02/21/19
14:24
Hot Stocks
Nintendo of America president, COO Reggie Fils-Aime to retire »

Nintendo announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$14.83

-0.21 (-1.40%)

14:23
02/21/19
02/21
14:23
02/21/19
14:23
Hot Stocks
Fiat Chrysler to propose EUR0.65 per share dividend »

Fiat Chrysler Automobiles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$43.43

-0.32 (-0.73%)

14:20
02/21/19
02/21
14:20
02/21/19
14:20
Options
20K iShares Brazil Fund Mar 44 - 46 call spreads sold at 60c »

20K iShares Brazil Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
02/21/19
02/21
14:17
02/21/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
02/21/19
02/21
14:16
02/21/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BZUN

Baozun

$34.55

-1.08 (-3.03%)

14:15
02/21/19
02/21
14:15
02/21/19
14:15
Options
Baozun put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THRM

Gentherm

$44.16

1.3 (3.03%)

14:11
02/21/19
02/21
14:11
02/21/19
14:11
Downgrade
Gentherm rating change  »

Craig-Hallum downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

PTC

PTC

$91.88

0.04 (0.04%)

14:08
02/21/19
02/21
14:08
02/21/19
14:08
Hot Stocks
New offering from PTC and ANSYS brings real-time simulation to design engineers »

PTC announced the release…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 14

    Mar

HSC

Harsco

$24.48

2.54 (11.58%)

14:06
02/21/19
02/21
14:06
02/21/19
14:06
Recommendations
Harsco analyst commentary  »

Harsco has opportunity to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

THRM

Gentherm

$44.10

1.24 (2.89%)

14:06
02/21/19
02/21
14:06
02/21/19
14:06
Downgrade
Gentherm rating change  »

Gentherm downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 01

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$277.66

-0.76 (-0.27%)

14:04
02/21/19
02/21
14:04
02/21/19
14:04
Periodicals
CEO of container ship giant Maersk sees global trade war escalation, FT says »

Moller-Maersk CEO Soren…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$277.66

-0.76 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSU

Tim Participacoes

$16.28

0.01 (0.06%)

13:58
02/21/19
02/21
13:58
02/21/19
13:58
Hot Stocks
Breaking Hot Stocks news story on Tim Participacoes »

TIM Participacoes trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$30.85

-0.01 (-0.03%)

13:55
02/21/19
02/21
13:55
02/21/19
13:55
Hot Stocks
AT&T sees discontinuing 3G service in early 2022 »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

  • 20

    Mar

PXD

Pioneer Natural

$137.13

-4.15 (-2.94%)

13:55
02/21/19
02/21
13:55
02/21/19
13:55
Options
Pioneer Natural put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

INVE

Identiv

$5.77

0.02 (0.35%)

13:55
02/21/19
02/21
13:55
02/21/19
13:55
Conference/Events
Identiv to participate in a conference call with Northland »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

GOOG

Alphabet

$1,100.85

-13.06 (-1.17%)

, GOOGL

Alphabet Class A

$1,106.69

-13.91 (-1.24%)

13:47
02/21/19
02/21
13:47
02/21/19
13:47
Periodicals
AT&T tells Bloomberg removing YouTube ads »

AT&T (T) said in an…

GOOG

Alphabet

$1,100.85

-13.06 (-1.17%)

GOOGL

Alphabet Class A

$1,106.69

-13.91 (-1.24%)

T

AT&T

$30.88

0.015 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 11

    Mar

  • 11

    Mar

  • 18

    Mar

  • 20

    Mar

SPCB

SuperCom

$1.68

(0.00%)

13:43
02/21/19
02/21
13:43
02/21/19
13:43
Hot Stocks
SuperCom secures new electonic monitoring contract in Southern Georgia »

SuperCom announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

NSRGY

Nestle

$0.00

(0.00%)

, DIS

Disney

$114.00

0.305 (0.27%)

13:38
02/21/19
02/21
13:38
02/21/19
13:38
Periodicals
YouTube sends memo to address 'brand safety' controvery, AdWeek reports »

YouTube (GOOG, GOOGL)…

NSRGY

Nestle

$0.00

(0.00%)

DIS

Disney

$114.00

0.305 (0.27%)

GOOGL

Alphabet Class A

$1,108.85

-11.75 (-1.05%)

GOOG

Alphabet

$1,103.04

-10.87 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 03

    Mar

  • 07

    Mar

  • 18

    Mar

CF

CF Industries

$43.96

-0.58 (-1.30%)

13:35
02/21/19
02/21
13:35
02/21/19
13:35
Options
CF Industries put volume heavy and directionally bearish »

Bearish flow noted in CF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 27

    Feb

  • 28

    May

MLNT

Melinta Therapeutics

$1.30

-0.035 (-2.62%)

13:32
02/21/19
02/21
13:32
02/21/19
13:32
Hot Stocks
Melinta Therapeutics announces one-for-five reverse stock split »

Melinta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLO

Valero

$84.85

-0.51 (-0.60%)

13:27
02/21/19
02/21
13:27
02/21/19
13:27
Conference/Events
Valero management to meet with JPMorgan »

Meeting to be held Boston…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

13:25
02/21/19
02/21
13:25
02/21/19
13:25
Conference/Events
The Federal Energy Regulatory Commission (FERC) to hold a meeting »

Open Commission Meeting…

MGM

MGM Resorts

$28.56

-0.26 (-0.90%)

13:24
02/21/19
02/21
13:24
02/21/19
13:24
Conference/Events
MGM Resorts management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.